Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katia Belaid

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Journal for Immunotherapy of Cancer|February 20, 2021
In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivityAdrianne L Jenner, Tyler Cassidy, Katia Belaid, et al.
Journal of Cheminformatics|August 7, 2025
VitroBert: modeling DILI by pretraining BERT on in vitro dataMuhammad Arslan Masood, Anamya Ajjolli Nagaraja, Katia Belaid, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Journal for Immunotherapy of Cancer|February 20, 2021
In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivityAdrianne L Jenner, Tyler Cassidy, Katia Belaid, et al.
Journal of Cheminformatics|August 7, 2025
VitroBert: modeling DILI by pretraining BERT on in vitro dataMuhammad Arslan Masood, Anamya Ajjolli Nagaraja, Katia Belaid, et al.
Pageof 1